Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
08/22/2013 | WO2013120229A1 METHOD FOR PREPARING AQUEOUS MANO PARTICLE SUSPENSIONS OF DERIVATIVES OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURAN ALIPHATIC ACID ESTERS |
08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
08/22/2013 | US20130217676 5ht2c receptor modulators |
08/22/2013 | US20130216588 Insulin-gold nanocluster, pharmaceutical composition for reducing blood glucose comprising the same, and method for detecting adipose cells in tissue by using the same |
08/21/2013 | EP2628733A1 Acylbenzene derivative |
08/21/2013 | EP2627770A2 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders |
08/21/2013 | EP2627638A1 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
08/21/2013 | EP2627632A1 Sulphonamide compounds and methods of making and using same |
08/21/2013 | EP2627340A1 A method of regulating plasma lipoproteins |
08/21/2013 | EP2358717B1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
08/21/2013 | CN203138934U Magnetic health-care mattress for treating osphyalgia, leg pain and bedsore |
08/21/2013 | CN1533374B Substitutled cyclohexane-1,4-diamine derivatives |
08/21/2013 | CN103261412A Antihuman CCR7 antibodies, hybridoma, nucleic acid, vector, cell, medicinal composition, and antibody-mmobilized carrier |
08/21/2013 | CN103261223A Human oncostatin M antibodies and methods of use |
08/21/2013 | CN103261197A Highly-soluble pyrroloquinoline quinone salt and method for producing same |
08/21/2013 | CN103261185A Continuous arycyclic compound |
08/21/2013 | CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators |
08/21/2013 | CN103260628A Use of hyaluronan for promoting angiogenesis |
08/21/2013 | CN103260608A Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid |
08/21/2013 | CN103260604A Viscous nutritional composition |
08/21/2013 | CN103255169A Replication-defective arenavirus vectors |
08/21/2013 | CN103254321A Method for extracting and purifying Phellinus vaninii polysaccharides of medicinal fungus Phellinus vaninii |
08/21/2013 | CN103254193A 黄嘌呤类化合物中间体及其制备方法 Xanthine compound intermediates and preparation method |
08/21/2013 | CN103254192A Xanthine compound, its salt, intermediates, preparation method and application |
08/21/2013 | CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
08/21/2013 | CN103254177A Modulators of atp-binding cassette transporters |
08/21/2013 | CN103254120A Spiro-azasugar quaternary ammonium salt compound, and preparation method and application thereof |
08/21/2013 | CN103254119A Inhibitors of sodium glucose co-transporter 2 and methods of their use |
08/21/2013 | CN103254107A Ezetimibe analogue and preparation method thereof |
08/21/2013 | CN103254053A Alpha-fluoro-chalcone type compound and preparation and application thereof |
08/21/2013 | CN103251954A Diabetes treating compound medicine for reducing side effect of rosiglitazone and preparation method thereof |
08/21/2013 | CN103251953A Flt3 inhibitors for immune suppression |
08/21/2013 | CN103251945A Multiple-variable dose regimen for treating tnfalpha-related disorders |
08/21/2013 | CN103251915A Traditional Chinese medicine composition for treating diabetes mellitus |
08/21/2013 | CN103251912A Medicament for treating diabetes |
08/21/2013 | CN103251887A Pharmaceutical composition for treating diabetes and indications thereof |
08/21/2013 | CN103251867A Chinese herbal compound medicine for treating diabetes mellitus and preparation method thereof |
08/21/2013 | CN103251828A Blood glucose reducing vinegar and blood glucose reducing pillow matched in use |
08/21/2013 | CN103251827A Traditional Chinese medicine composition for treating diabetes mellitus and preparation method thereof |
08/21/2013 | CN103251814A Traditional Chinese medicine preparation for adjusting hypertension, hyperlipemia and hyperglycemia |
08/21/2013 | CN103251799A Red ginseng and fragrant solomonseal rhizome tablet |
08/21/2013 | CN103251786A Medicament for treating hyperlipaemia and preparation method thereof |
08/21/2013 | CN103251764A Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
08/21/2013 | CN103251747A Traditional Chinese medicine formulation capable of reducing lipid and dredging collaterals and preparation method thereof |
08/21/2013 | CN103251746A Traditional Chinese medicine composition for reducing blood sugar and invigorating kidney and strengthening yang |
08/21/2013 | CN103251743A Formulation for enhancing immunity, improving cardiovascular function and delaying senescence |
08/21/2013 | CN103251738A Chinese herbal medicine composite for treating hyperlipidaemia |
08/21/2013 | CN103251737A Yindan capsule |
08/21/2013 | CN103251736A Traditional Chinese medicine formula for losing weight |
08/21/2013 | CN103251710A Medicine composite for preventing or treating diabetic nephropathy and application of medicine composite |
08/21/2013 | CN103251700A Red sage root and pseudo-ginseng tablet |
08/21/2013 | CN103251697A Medicinal composition for treating diabetic peripheral neuropathy, and preparation method thereof |
08/21/2013 | CN103251686A Composition for adjusting hyperlipemia and preparation method of composition |
08/21/2013 | CN103251685A Rumex nepalensis spreng extract and application of the same in drug preparation |
08/21/2013 | CN103251675A Kudzu flavone self-microemulsifying dropping pill and preparation method thereof |
08/21/2013 | CN103251648A Iron-based montmorillonite medicine for treating hyperphosphatemia and iron-deficiency anemia and preparation method of iron-based montmorillonite medicine |
08/21/2013 | CN103251631A Salicylate conjugates useful for treating metabolic disorders |
08/21/2013 | CN103251616A Application of Aspeverin in preparation of blood sugar lowering medicines |
08/21/2013 | CN103251594A Repaglinide/metformin combo tablet |
08/21/2013 | CN103251593A Repaglinide/metformin composition |
08/21/2013 | CN103251579A Substituted acylanilides and methods of use thereof |
08/21/2013 | CN103251572A Preparation method of theaflavin enteric microcapsule, as well as product prepared by preparation method and application of product |
08/21/2013 | CN103251571A Potassium ion binding polymers for pharmaceutical compositions |
08/21/2013 | CN103251567A Agomelatine troche and preparation method thereof |
08/21/2013 | CN103251065A Domesticated sika deer bone meal as well as preparation method thereof and sika deer bone chewable tablet prepared from bone meal |
08/21/2013 | CN103251061A Animal bone calcium micro-nano powder and preparation method thereof |
08/21/2013 | CN103250950A Full-nutritional food combination and preparation method thereof |
08/21/2013 | CN103250821A Lipid-lowering weight reducing tea and preparation method thereof |
08/21/2013 | CN102949463B Traditional Chinese medicine composition for reducing blood fat |
08/21/2013 | CN102934815B Donkey meat sausage |
08/21/2013 | CN102743578B Traditional Chinese medicine preparation for promoting blood circulation to remove meridian obstruction |
08/21/2013 | CN102626224B Eyesight improving agent composited by wild berries and Chinese medicines and preparation method thereof |
08/21/2013 | CN102580087B In-situ adipocyte composite inhibitor for local weight loss and body care of human bodies and preparation method thereof |
08/21/2013 | CN102579422B Application of flavonoids compound in preparation of anti-metabolic disease medicine |
08/21/2013 | CN102524768B Medication or health product prepared with djulis for hyperlipidemia and hypercholesterolemia |
08/21/2013 | CN102512584B Chinese medicinal pill for treating diabetic complications |
08/21/2013 | CN102512520B Normal-temperature preparation method for ultrafine powder hawthorn |
08/21/2013 | CN102397447B Medicinal composition and granular medicine and preparation method and application thereof |
08/21/2013 | CN102293925B Preparation method of Jiangzhiling tablets |
08/21/2013 | CN102258655B External traditional Chinese medicine ointment preparation for treating diabetic foot |
08/21/2013 | CN102171329B Lactic acid bacterium having high oxalic acid decomposition ability |
08/21/2013 | CN102106884B Medicinal composition having immunity-regulating function |
08/21/2013 | CN102091083B Petroleum ether extract of traditional Chinese medicine for preventing and treating glucose and lipid metabolic disturbance and preparation method thereof |
08/21/2013 | CN101981015B 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents |
08/21/2013 | CN101961375B Extractive of Pu'er tea and preparation method thereof |
08/21/2013 | CN101815443B Foodstuff of tablets or capsules |
08/21/2013 | CN101780268B Method and reagent for diagnosing, preventing and treating insulin resistance |
08/21/2013 | CN101664553B Stabilization of hypoxia inducible factor (HIF) alpha |
08/21/2013 | CN101663030B Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
08/21/2013 | CN101600700B Novel 2-aminooxazolines as taar1 ligands for CNS disorders |
08/21/2013 | CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar |
08/20/2013 | US8513293 Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal |
08/20/2013 | US8513281 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
08/20/2013 | US8513189 Albumin fusion proteins |
08/20/2013 | US8512718 Pharmaceutical composition for topical application |
08/20/2013 | CA2804129C Manufacturing method for dried earthworm powder |
08/20/2013 | CA2735107C Co-precipitated salts of fatty acids |
08/20/2013 | CA2687492C A herbal composition, method for preparing the same and use thereof for treating diabetes mellitus |
08/20/2013 | CA2587924C Oral compositions for absorption of phosphorus compounds |
08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |